Drug FDA Class II Ongoing Quality
Desmopressin Nasal Spray, USP, 10 mcg/0.1 mL, 5 mL bottle (50 doses), Rx only, Mfg by: Apotek inc., Toronto, Ontario, Canada, M9L 1T9, Mfg for: Apotek Corp., Weston, FL 33326, NDC 60505-0815-0
Apotex Corp. Published Apr 22, 2026
Risk level
Class IIMay cause a temporary or reversible health problem; slight chance of serious harm.
Severity score 60/100
What should you do?
- Check whether you have this product, using the lot codes, UPCs, and dates listed below.
- Do not eat, serve, or sell the affected product.
- Return it to the place of purchase for a refund, or throw it away in a sealed bag so people and animals can’t get to it.
- Contact Apotex Corp. or your place of purchase with questions, and see the source record below for full details.
Reason for recall
Defective container: defect in a batch of bottle caps, specifically involving dislodged or missing cap liners.
Affected products (1)
Desmopressin Nasal Spray, USP, 10 mcg/0.1 mL, 5 mL bottle (50 doses), Rx only, Mfg by: Apotek inc., Toronto, Ontario, Canada, M9L 1T9, Mfg for: Apotek Corp., Weston, FL 33326, NDC 60505-0815-0
DESMOPRESSIN ACETATE · N/A
NDC: 60505-0815, 60505-0815-0
Code info: Lot #: VM4231, Exp 06/30/2027
Affected areas
Nationwide
Timeline
- InitiatedApr 8, 2026
- PublishedApr 22, 2026
- Recall number
- D-0510-2026
- Agency
- U.S. Food and Drug Administration
- Country
- US
FDA records come from the openFDA drug enforcement-report dataset — the agency's full weekly enforcement list. Most entries are not issued as consumer press releases, so they won't appear on fda.gov/recalls or in a web search. The source record link above resolves this exact recall by its number.